A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without
UT Southwestern immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms of nonalcoholic fatty liver disease and po
UT Southwestern immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms of nonalcoholic fatty liver disease and potential liver failure.
Discovery could pave way for development of therapies to treat non-alcoholic steatohepatitis archyde.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archyde.com Daily Mail and Mail on Sunday newspapers.